We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+2.05%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$101B
AUM Growth
+$37.4B
Cap. Flow
+$36.7B
Cap. Flow %
36.22%
Top 10 Hldgs %
21.17%
Holding
5,633
New
1,585
Increased
2,056
Reduced
1,281
Closed
669

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Consumer Discretionary 5.03%
3 Financials 3.61%
4 Healthcare 3.25%
5 Industrials 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INCR
4926
Intercure
INCR
$55.2M
$18.3K ﹤0.01%
+11,434
New +$18K
VFF icon
4927
Village Farms International
VFF
$235M
$18.2K ﹤0.01%
23,565
-62,849
-73% -$52.5K
UBX
4928
DELISTED
Unity Biotechnology
UBX
$17.9K ﹤0.01%
+18,332
New +$22.8K
BCAB icon
4929
CALL
BioAtla
BCAB
$5.59M
$17.7K ﹤0.01%
+600
New +$50.4K
MRSN
4930
DELISTED
Mersana Therapeutics
MRSN
$17.3K ﹤0.01%
484
-2,781
-85% -$144K
RLYB icon
4931
Rallybio
RLYB
$86.6M
$16.5K ﹤0.01%
2,143
-153
-7% -$1.28K
FTHM icon
4932
Fathom Holdings
FTHM
$28.2M
$15.6K ﹤0.01%
+10,212
New +$22.2K
TNXP icon
4933
Tonix Pharmaceuticals
TNXP
$157M
$15.4K ﹤0.01%
+468
New +$9.73K
NKLA
4934
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
$15.4K ﹤0.01%
+12,900
New +$36.8K
RANI icon
4935
Rani Therapeutics
RANI
$95.6M
$14.9K ﹤0.01%
+10,863
New +$22.8K
OCGN icon
4936
Ocugen
OCGN
$410M
$14.3K ﹤0.01%
+17,706
New +$16.2K
KPTI icon
4937
Karyopharm Therapeutics
KPTI
$168M
$14.1K ﹤0.01%
+1,386
New +$16.8K
ANY icon
4938
PUT
Sphere 3D
ANY
$14.6M
$13.4K ﹤0.01%
+1,420
New +$16.5K
PSNY icon
4939
Polestar Automotive Holding UK
PSNY
$1.98B
$13.4K ﹤0.01%
425
-2,526
-86% -$91.6K
FRGE
4940
DELISTED
Forge Global Holdings
FRGE
$12.5K ﹤0.01%
899
-9,125
-91% -$150K
ANY icon
4941
CALL
Sphere 3D
ANY
$14.6M
$10.7K ﹤0.01%
+1,130
New +$13.1K
ACXP icon
4942
Acurx Pharmaceuticals
ACXP
$6.1M
$10.2K ﹤0.01%
+627
New +$18.9K
OTLY
4943
CALL
Oatly Group
OTLY
$417M
$9.88K ﹤0.01%
+745
New +$11K
ADAP
4944
DELISTED
Adaptimmune Therapeutics
ADAP
$8.92K ﹤0.01%
+16,563
New +$12.1K
SCLX icon
4945
Scilex Holding
SCLX
$48.1M
$8.83K ﹤0.01%
591
-6,980
-92% -$177K
BNGO icon
4946
CALL
Bionano Genomics
BNGO
$12.7M
$8.65K ﹤0.01%
+500
New +$8.55K
WKHS icon
4947
Workhorse Group
WKHS
$29.5M
$8.37K ﹤0.01%
+80
New +$10.9K
ZOM
4948
DELISTED
Zomedica Corp.
ZOM
$7.72K ﹤0.01%
+64,350
New +$8.1K
AMRN
4949
Amarin Corp
AMRN
$284M
$4.99K ﹤0.01%
+515
New +$5.51K
SBEV icon
4950
Splash Beverage Group
SBEV
$3.6K ﹤0.01%
+559
New +$4.63K

Similar funds

Squarepoint's Q4 2024 Portfolio in Review

As of Q4 2024, Squarepoint held 5,633 positions worth $101B, up 59% from $63.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Squarepoint deployed $36.7B of net new capital in Q4 2024, opening 1,585 new positions and adding to 2,056 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $2.67B trimmed.

  • Squarepoint's largest Q4 2024 buy was State Street SPDR S&P 500 ETF Trust: 2,432,087 shares worth $1.43B.
  • Squarepoint added most to NVIDIA in Q4 2024, an estimated $1.29B increase.
  • Squarepoint's biggest Q4 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $2.67B.
  • Squarepoint fully exited State Street Financial Select Sector SPDR ETF in Q4 2024, selling an estimated $86.3M.
  • Squarepoint's ten largest holdings make up 21% of its $101B portfolio in Q4 2024.
  • Squarepoint opened 1,585 new positions and closed 669 in Q4 2024.
  • Squarepoint's portfolio value rose 59% quarter-over-quarter to $101B.

Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.